Adeshwar Meditex Ltd (ADESHWAR)

About

Adeshwar Meditex Ltd operates in Healthcare Research, Analytics & Technology within the Healthcare sector.

Face value: ₹10

Market cap

₹23 Cr

P/E

18.6×

P/B

—

Dividend yield

0%

ROE

—

ROCE

—

Debt / equity

—

OPM

4.9%

EPS (TTM)

₹0.9

Book value

—

52-week high

—

52-week low

—

434 historical price candles were omitted because the exchange source has not been verified.

Only one verified price point is available. The trend chart will appear when more exchange closes are stored.

Quick read

rule-based

Pros

No positive flags triggered.

Cons

−Thin operating margin of 4.9%
−Profit declined 5.6% a year over the last 5 years
−Revenue shrank over the last 5 years (-3.2% a year)

Research score

Structured signal from quality, growth, valuation and momentum.

25/100

Business quality: 11
Growth: 0
Valuation: 64

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Syngene International LimitedSYNGENESYNGENE	₹14,586 Cr	₹14,595 Cr	₹3,600 Cr	₹803 Cr	24.6%	₹221 Cr	8.5%	9.8%	6.6%	-32
Indegene LimitedINDGNINDGN	₹14,303 Cr	₹14,303 Cr	₹3,813 Cr	₹638 Cr	17.6%	₹401 Cr	11.4%	17.9%	13.9%	79
Suven Life Sciences LimitedSUVENSUVEN	₹8,139 Cr	₹8,139 Cr	₹9 Cr	₹-366 Cr	—	₹-352 Cr	—	-78.4%	-78.8%	72
Vimta Labs LimitedVIMTALABSVIMTALABS	₹2,612 Cr	₹2,631 Cr	₹336 Cr	₹112 Cr	27.3%	₹61 Cr	12.9%	17.4%	13.6%	179
Bilcare LimitedBIBI	₹227 Cr	₹896 Cr	₹788 Cr	₹45 Cr	5.7%	₹-29 Cr	-7.1%	1.5%	-6%	78
Take Solutions LimitedTAKETAKE	₹187 Cr	₹187 Cr	₹85 Cr	₹-2 Cr	-3.5%	₹13 Cr	20%	18.5%	42.1%	-7
Jeevan Scientific Technology LtdJSTLJSTL	₹169 Cr	₹186 Cr	₹62 Cr	₹10 Cr	16%	₹0 Cr	1.7%	5.4%	1.7%	-109
Novelix Pharmaceuticals LtdNOVELIXNOVELIX	₹167 Cr	₹167 Cr	₹9 Cr	₹-3 Cr	-29.9%	₹-2 Cr	-23.6%	-28.1%	-28.5%	57
Globalspace Technologies LtdGSTLGSTL	₹103 Cr	—	₹25 Cr	₹11 Cr	5.9%	₹7 Cr	-1.4%	—	—	—
Adeshwar Meditex LtdADESHWARADESHWAR	₹23 Cr	—	₹56 Cr	₹3 Cr	4.9%	₹1 Cr	2.3%	—	—	—
Vanta Bioscience LtdVANTABIOVANTABIO	₹15 Cr	—	₹2 Cr	₹1 Cr	56.6%	₹0 Cr	6%	—	—	—

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Standalone figures · ₹ crore

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	66	65	82	80	84	56
COGS	55	55	70	70	74	47
Gross profit	11	10	13	10	9	9
	7	6	8	5	5	6
Operating profit (EBITDA)	5	3	5	5	4	3
OPM %	7%	5.2%	6.3%	6.5%	5.2%	4.9%
Depreciation	0	0	1	1	1	0
Interest	2	2	2	2	1	1
	0	0	0	0	0	0
Profit before tax	2	1	3	3	3	2
Tax	1	0	1	1	1	1
Tax %	28.2%	33.6%	28.6%	28%	26.2%	31.2%
	2	1	2	2	2	1
PAT margin %	2.6%	1.2%	2.5%	2.5%	2.5%	2.3%
EPS (₹)	1.6	0.6	1.4	1.4	1.4	0.9
Annual report	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	—

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	—	—	—	—	—	—
Reserves	—	—	—	—	—	—
Borrowings	—	—	—	—	—	—
	62	73	67	64	72	50
Total equity & liabilities	62	73	67	64	72	50
Fixed assets	—	—	—	—	3	3
CWIP	—	—	—	—	—	—
Investments	0	0	0	0	0	0
	62	72	67	64	69	48
Total assets	62	73	67	64	72	50

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	3	-2	6	1	4	5
	1	-1	-1	0	1	0
	-3	4	-5	-1	-3	-7
Net cash flow	1	1	-0	1	2	-2
Free cash flow	3	-4	6	1	4	5
CFO / Operating profit %	69.4%	-72.2%	114.5%	28.8%	87.2%	180.1%

Compounded sales growth

7 years: —
5 years: -3%
3 years: -12%
1 year: -33%

Compounded profit growth

7 years: —
5 years: -6%
3 years: -15%
1 year: -39%

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Standalone figures

Ratio	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	17.1%	15.2%	15.6%	12.6%	11.1%	16.2%
EBITDA margin %	7%	5.2%	6.3%	6.5%	5.2%	4.9%
EBIT margin %	6.5%	4.6%	5.6%	5.7%	4.6%	4.2%
PAT margin %	2.6%	1.2%	2.5%	2.5%	2.5%	2.3%
Working capital
Receivable days	—	—	—	—	—	—
Inventory days	174	168	128	139	127	159
Payable days	—	—	—	—	—	—
NWC days	—	—	—	—	—	—
Leverage
Current ratio	1.59	1.76	1.9	2.06	2.03	4.52
Debt to EBITDA	—	—	—	—	—	—
Debt to equity	—	—	—	—	—	—
Interest coverage	2.1	1.6	2.4	2.4	3.1	4
Asset turnover	1.06	0.89	1.23	1.25	1.16	1.12
Return ratios
Return on assets %	2.7%	1.1%	3.1%	3.1%	2.9%	2.5%
Return on capital employed %	17.1%	10.4%	13.9%	13.1%	10.9%	6.1%
Return on equity %	—	—	—	—	—	—

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2024	Mar 2025	Sep 2025	Mar 2026
	57.55%	57.55%	57.55%	57.68%
FII	0%	0%	0%	0%
DII	0%	0%	0%	0%
Government	0%	0%	0%	0%
	42.45%	42.45%	42.45%	42.32%
No. of shareholders	182	188	187	192

Promoter holding up 0.13 percentage points since Sep 2024.

Ashalata RautWhole Time Director
Krishnojirao Nagaraja RaoWhole Time Director
Mr. Nagaraja Rao AbhinandanExecutive Director
Mr. Raghupathy K BhatNon - Executive Independent Director
Mr. Prashant RaneChief Financial Officer

Current officeholders as filed with BSE. A person holding two offices is listed once per office.

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

No fund holdings on record

No scheme among the 32 fund houses on record reported a position in Adeshwar Meditex Ltd. Portfolios are published monthly by each AMC; coverage is still partial.

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

7

Annual reports

5

Documents link to external sources (exchange filings, company investor pages).

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

No events on record

Corporate actions, results dates and filings will appear here once ingested.

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

7 announcementsExport CSV

29 Aug 2026, 3:20 pmCompany Update

Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Publication PDF

27 Aug 2026, 6:35 pmCorp. Action

Book Closure Intimation For 19Th Annual General Meeting Of The Company To Be Held On September 23, 2026.

Book Closure PDF

27 Aug 2026, 6:30 pmAGM/EGM

Notice Of 19Th Annual General Meeting Of The Company To Be Held On 23Rd September, 2026 Along With Annual Report For The FY 2025-26.

AGM PDF

27 Aug 2026, 6:24 pmOthers

Reg. 34 (1) Annual Report.

Reg. 34 (1) Annual Report PDF

27 Aug 2026, 4:27 pmCompany Update

Announcement under Regulation 30 (LODR)-Resignation of Director

Resignation of Director PDF

26 Aug 2026, 6:51 pmBoard Meeting

Board Meeting Outcome for Meeting Of Board Of Directors Held On Wednesday, 26Th August, 2026 At 4:00 PM (IST).

Outcome of Board Meeting PDF

22 Aug 2026, 6:04 pmBoard Meeting

Board Meeting Intimation for Meeting Of Board Of Directors Of Adeshwar Meditex Limited To Be Held On August 26, 2026 At 04:00 PM (IST) At The Registered Office Of The Company.

Exchange filing PDF

Date	Category	Subject	Filing
29 Aug 2026, 3:20 pm	Company Update Newspaper Publication	Announcement under Regulation 30 (LODR)-Newspaper Publication	PDF
27 Aug 2026, 6:35 pm	Corp. Action Book Closure	Book Closure Intimation For 19Th Annual General Meeting Of The Company To Be Held On September 23, 2026.

Loading announcements…

Adeshwar Meditex Ltd

About

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Ratios

Ratio timeline

Shareholding

Quarterly record

Board and management

F&O

Not in the F&O segment

Fund holders

No fund holdings on record

Documents

Announcements

Annual reports

Events

No events on record

Announcements

Announcements

Annual reports

Ratio timeline

Quarterly record

Board and management

Not in the F&O segment

No events on record

No fund holdings on record

Profit & loss

Balance sheet

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth